Environment and Gender Factors Play Bigger Role On Multiple Scleroris

Gender seems to have a big factor in people developing multiple sclerosis, with the disease now predominant among women. It seems that women in general may develop the disease on a ratio of 3.2 to 1 compared to men.

With genetic factors already having been ruled out as a probable cause of the autoimmune disease, more researchers and scientists are closely looking into environmental factors which may have a role in increasing the risk of MS in women.

A medical scientific conference on the association of multiple sclerosis and gender recently took off which was organized by the European Charcot Foundation.

The said medical conference brought together almost 400 scientists and experts on multiple sclerosis from around the world to discuss and share different scientific views concerning the shift of the gender ratio concerning the disease.

Multiple sclerosis is a degenerative disease that affects the central nervous system that can lead to severe disability in due time.

The medical conference aims to raise the attention towards gender related issues especially when it comes to treating multiple sclerosis. More and more scientists believe that individualized MS treatments especially among men and women, will lead to better results in the future.

According to Prof. O.R. Hommes, chairman of the European Charcot Foundation, "This conference has raised the simple question whether females with MS should be treated differently than males".

A look at how environmental factors can increase the risk of MS in women is also being discussed especially smoking, viral infections, hygiene changes, vitamin D deficiency and a host of other factors. One of the unique case in point that researchers try to look into is the effect of pregnancy on the progression of MS.

Studies have shown that the disease practically disappears during the last trimester of the pregnancy. This approach to studying multiple sclerosis in the future, with gender differences in mind, will eventually provide answers in the future as clinical trials are already underway until the end of 2009.

Source: http://www.medicalnewstoday.com/articles/129672.php

 
You can leave a response, or trackback from your own site.